Bristol-Myers Squibb Foundation: Grants for Disease

OVERVIEW: The Bristol-Myers Squibb Foundation concentrates its disease related granting in the U.S. on cancer and HIV.

IP TAKE: A major through-line in this foundation’s disease grantmaking is serving vulnerable populations and it often partners with large organizations in an effort to do so. Bristol-Myers Squibb does have an eye on improving community based healthcare services, but smaller outfits may find it difficult to gain the BMS Foundation’s funding attentions.

OVERVIEW: The Bristol-Myers Squibb Foundation (BMS) “seeks to improve health outcomes of populations disproportionately affected by serious diseases.” BMS works toward improving those health outcomes in a number of different capacities including strengthening healthcare worker capacity, promoting integrated health care, and improving community-based support services.

In the U.S. the BMS Foundation focuses on cancer care and support (lung and skin), and HIV. The foundation was once a significant Type 2 diabetes grantmaking, but that program ended in 2013. A common theme throughout BMS’ grantmaking is focusing on organizations serving U.S. populations that are disproportionately affected by each disease. The majority of BMS’ disease grants are awarded out of its Specialty Care for Vulnerable Populations program.

The BMS Foundation’s grantmaking associated with HIV largely revolves around prevention, education, and access to HIV care and treatment.

The foundation’s support of cancer largely revolves around states that have the highest lung and skin cancer burdens. Its grantmaking is aimed at reducing that burden in underserved populations through prevention, detection, and education efforts.

The foundation also supports work on Hepatitis B and C in India, China and sub-Saharan Africa, on HIV in in Africa, and on Type 2 Diabetes in China and India.

Much of BMS' grant funding goes to major institutions performing research or medical interventions in the US and aboard, including hospitals, universities, and other foundations. Recent grants have ranged from $15,000 to $600,000, with most being under $100,000.

The BMS Foundation’s tax filings indicates that it does accept unsolicited LOIs, but it doesn’t offer clear application guidelines. Many of the the foundation's individual initiatives have their own websites with further information. The best bet for grantseekers is to contact the foundation directly.

PEOPLE:

  • Catharine Grimes, Director of Corporate Philanthropy, BMS Foundation
  • Patricia Mae Doykos, Director, BMS Foundation

LINKS: